Kubient, Inc.: Nasdaq/NYSE listing notice — Kubient receives Nasdaq deficiency notice for bid price below $1; 180-day cure until July 11, 2023

Kubient, Inc.

Nasdaq notified Kubient on Jan 12, 2023 that its common stock failed to maintain minimum bid price of $1.00 for 30 consecutive business days.
Company has 180 calendar days, until July 11, 2023, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days.
Non-compliance could lead to delisting from the Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Kubient, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

January 12, 2023, Kubient, Inc. (the “Company”) received a deficiency notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), indicating that, based upon the closing bid price of the Company’s common stock, par value $0.00001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company wa

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001140361-23-001631

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.